Flores Osvaldo

USNatural personCEO

Insider

Flores Osvaldo

USNatural personCEO

Transactions

Issuers

Buys / Sells

0/0

Last tx

02 Feb 2023

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Century Therapeutics, Inc.	637,500	reported	02 Feb 2023	tx 3+1,590,000

Recent transactions

Date	Type	Issuer	Qty	Signals
02 Feb 2023	GRANT_AWARD	Century Therapeutics, Inc.	637,500	deriv
02 Feb 2023	GRANT_AWARD	Century Therapeutics, Inc.	637,500	deriv
25 Jan 2022	GRANT_AWARD	Century Therapeutics, Inc.	315,000	deriv

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Century Therapeutics, Inc.	637,500	reported	02 Feb 2023	tx 3+1,590,000

Recent transactions

Date	Type	Issuer	Qty	Signals
02 Feb 2023	GRANT_AWARD	Century Therapeutics, Inc.	637,500	deriv
02 Feb 2023	GRANT_AWARD	Century Therapeutics, Inc.	637,500	deriv
25 Jan 2022	GRANT_AWARD	Century Therapeutics, Inc.	315,000	deriv